6 dage ved steady state, hvilket giver små koncentrationsudsving over doseringsintervallet på 24 timer.
At steady state, the half-life of lasofoxifene in postmenopausal women is approximately 6 days, resulting in small fluctuations in concentrations over the 24-hour dosing interval.